Advantages of Aquablation system for patients with BPH

A full market release of the HYDROS System is expected within the current quarter.

The data were presented at the recent American Urological Association Annual Meeting.

The new Category I code will become effective on January 1, 2026.

“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.

“Our results demonstrated that treatment with [the] Optilume BPH procedure resulted in significant symptom relief while still preserving erectile and ejaculatory function,” said Olivia Copelan, MD.

"The results showed the contemporary Aquablation procedural safety in Japanese men is exceptional in a broad range of prostate sizes along with significant symptom reduction," says Nobuyuki Hinata, MD.